Kurome
Akira Kurome, Kashiwa JP
Patent application number | Description | Published |
---|---|---|
20100194393 | GRADIENT COIL DEVICE, MAGNETIC RESONANCE IMAGING DEVICE, AND METHOD OF DESIGNING COIL PATTERN - There is provided a gradient coil device which can suppress any generation of an error magnetic field and thus an eddy current, and which can improve the image quality of a cross-sectional image. An MRI device includes a first coil generating a linear magnetic field distribution at an imaging region of the MRI device, and a second coil which suppresses any leakage of a magnetic field from the first coil to a static-magnetic-field coil device that generates a uniform magnetic field distribution at the imaging region. | 08-05-2010 |
20100321019 | GRADIENT MAGNETIC FIELD COIL DEVICE AND MAGNETIC RESONANCE IMAGING APPARATUS - When the gradient magnetic field | 12-23-2010 |
20120176137 | GRADIENT MAGNETIC FIELD COIL AND MAGNETIC RESONANCE IMAGING DEVICE - In the magnetic resonance imaging device, the distance between the first and second coils is different in the circumferential direction and has a first region (A | 07-12-2012 |
20130335088 | GRADIENT COIL DEVICE AND MAGNETIC RESONANCE IMAGING DEVICE - A gradient coil device includes a major axis gradient coil, having an ellipse in a cross section generating a gradient magnetic field inclined in a major axis direction of the ellipse at a magnetic field space; and a minor axis gradient coil, having an ellipse in a cross section generating a gradient magnetic field inclined in a minor axis direction of the ellipse at the magnetic field space. A length of the minor axis field coil in the center axis direction is shorter than a length of the major axis gradient coil in the center axis direction. A maximum value of a residual magnetic field generated by the minor axis gradient coil at a space outside the magnetic field space is equal to or smaller than a maximum value of a residual magnetic field generated by the major axis gradient coil at a space outside the magnetic field space. | 12-19-2013 |
Akira Kurome, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20090066332 | MAGNETIC RESONANCE IMAGING APPARATUS AND GRADIENT MAGNETIC FIELD COIL - An MRI apparatus excellent in magnetic field generation efficiency is provided. According to this invention, a main coil ( | 03-12-2009 |
Akira Kurome, Kashiwa-Shi JP
Patent application number | Description | Published |
---|---|---|
20080211504 | MAGNETIC RESONANCE IMAGING APPARATUS - [PROBLEMS] A magnetic resonance imaging apparatus in which vibration of a gradient magnetic field coil is reduced, the vibration is not transmitted to a static magnetic field correcting unit, and the space can be saved. | 09-04-2008 |
Kazuya Kurome, Hyogo JP
Patent application number | Description | Published |
---|---|---|
20100322828 | NANOPARTICLE-DISPERSED HIGH-PERFORMANCE LIQUID FLUID, PRODUCTION METHOD AND APPARATUS FOR THE FLUID, AND LEAK DETECTION METHOD FOR THE FLUID - Suppression or enhancement of various properties of a liquid fluid is aimed by improving uniform dispersion of nanoparticles by means of making a state in which no oxidized film exists on the surfaces of the nanoparticles to be dispersed in the liquid fluid. The location of the liquid fluid is confirmed with ease by enhancing the brightness of light emission of the fluid through uniform dispersion of the nanoparticles in the liquid fluid containing a material having a flame reaction. In this way, as to liquid fluids utilized in various industries, it is possible to offer a technology to desirably enhance or suppress a property desired to be enhanced and a property desired to be suppressed among various properties that its constituents have. | 12-23-2010 |
Toru Kurome, Hyogo JP
Patent application number | Description | Published |
---|---|---|
20090203750 | 5-HT2C Receptor Agonists as Anorectic Agents - This invention relates to compounds which modulate receptors of the 5-HT2 family of receptors, and particularly to compounds which modulate 5-HT2C receptors. Compounds of the invention include agonists and selective agonists for the 5-HT2C receptor Compounds of the invention include selective agonists for the 5-HT2C receptor which exhibit significantly less or no agonist activity on the 5-HT2A receptor and/or the 5-HT2B receptor. Compounds of this invention are those of Formula I and pharmaceutically acceptable salts, esters and solvates (including hydrates) wherein variables are defined in the specification hereof. | 08-13-2009 |